Sofpironium bromide: Phase IIb data

A double-blind, U.S. Phase IIb trial in 189 patients with primary axillary hyperhidrosis showed that BBI-4000 met

Read the full 177 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE